Business Wire

EASE Secures First International Lender to Expand Equipment-as-a-Service Model in South Africa

14.4.2025 14:02:00 CEST | Business Wire | Press Release

Share

EASE South Africa has secured its first international lender to expand a revolutionary new model that provides clinics and hospitals with access to high-end medical equipment. EASE installs state-of-the-art PET-CT and MRI scanners, surgical robots, and other high-value machines with healthcare providers across South Africa.

The approach allows hospitals and clinics to pay on a per-scan or per-event basis, aligning their costs with revenue. Standard Bank is the first international lender to fund this innovative model.

The initiative is already making an impact, with installations of a surgical robot in one South African metropolitan hospital and a PET-CT scanner in another densely populated underserved region.

Without the burden of heavy upfront equipment costs, a longstanding barrier for many healthcare centres in accessing the latest technology, capital is freed up for priorities such as increasing hospital beds and nursing staff. A first-of-its-kind for Africa, this initiative is set to change the healthcare landscape for many hospitals and clinics.

“Securing our first international lender serves as a great support to our mission of transforming healthcare delivery in Africa,” said Imraan Soomra, CEO of EASE. “By removing the financial hurdles that limit access to advanced medical technology, our model gives hospitals and clinics the flexibility to expand care, hire more clinicians, and grow their infrastructure to better serve patients.”

By linking equipment costs with revenues and offering an off-balance-sheet equipment solution, EASE’s approach helps healthcare providers at once address both immediate and long-term challenges in delivering medical care. With a robust pipeline, EASE is on track to revolutionise healthcare access in South Africa. Its vision extends beyond this initial rollout, with plans to expand into additional sectors and markets.

EASE’s equipment-as-a-service model has been proven with three installations in the past year. Commissioning of a PET-CT scanner at the Precision Nuclear Oncology and Theranostics facility (PNOAT) in Rustenburg, South Africa, earlier this year follows the deployment of a Da Vinci surgical robot in KwaZulu-Natal, South Africa, and an advanced MRI diagnostic imaging system in Akwatia, Ghana.

"Equipment-as-a-service models that avoid capital expenditure and align costs with revenue generation are increasingly important in the healthcare sector," said Dr. Phumudzo Nemutaduni, a trailblazing nuclear physician who worked with EASE to install a PET-CT scanner at the PNOAT facility through her company, the Nuclear Med Group, a leading provider of nuclear medicine services across South and Southern Africa. "By enabling hospitals and clinics to access critical medical equipment without large upfront costs, such solutions can support sustainable growth and infrastructure expansion, improving healthcare accessibility in the long term.”

Photos: https://www.dropbox.com/scl/fo/gcrl5y98hdncold4wmgag/AP9x3S8ixRx09_-FXUU_ZDQ?rlkey=eim97zcyibratne63kgfb7cl1&st=qq6eb50g&dl=0

About EASE

Equipment-as-a-Service (EASE®) is a pay-per-use program that provides businesses and organisations with cost-effective access to state-of-the-art healthcare equipment – and maintenance, training and support – with terms that match their circumstances and business needs. EASE South Africa is a subsidiary of EASE Holdings BV which is headquartered in the Netherlands and has operations in multiple African countries. To find out more about EASE, visit https://www.easeglobal.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250403966834/en/

Contacts

Media Contacts:
EASE Holdings
Cydney Bell
press@easeglobal.com
+254 791 854 851

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press Release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye